Paul J Mainella, MD in Barrington, RI - Emergency Medicine

Paul J Mainella, MD is a Emergency Medicine physician based in Barrington, Rhode Island. Paul J Mainella is licensed to practice in Massachusetts (license number 73346) and his current practice location is 20 Linden Rd, Barrington, Rhode Island. He can be reached at his office (for appointments etc.) via phone at (401) 289-2212.

NPI number for Paul J Mainella is 1710037833 and his current mailing address is 20 Linden Rd, Barrington, Rhode Island. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1710037833.

Contact Information

	Paul J Mainella, MD
	20 Linden Rd, Barrington, RI 02806-3822
	(401) 289-2212
	Not Available

Physician's Profile

Full Name	Paul J Mainella
Gender	Male
Speciality	Emergency Medicine
Location	20 Linden Rd, Barrington, Rhode Island
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1710037833
Provider Enumeration Date: 01/11/2007
Last Update Date: 07/08/2007

Medical Identifiers

Medical identifiers for Paul J Mainella such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1710037833	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207P00000X	Emergency Medicine	73346 (Massachusetts)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Paul J Mainella is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Paul J Mainella, MD 20 Linden Rd, Barrington, RI 02806-3822 Ph: (401) 289-2212	Paul J Mainella, MD 20 Linden Rd, Barrington, RI 02806-3822 Ph: (401) 289-2212

News Archive

Palomar Medical resolves patent issue with Alma Lasers

Palomar Medical Technologies has announced the resolution of its on- going patent infringement and trade dress infringement lawsuit against Alma Lasers, Inc.

Racial gaps persist in women's heart-health awareness

Racial gaps exist in women's heart-health awareness, women's knowledge of heart attack warning signs requires attention and nearly half of women report they would not call 9-1-1 if they were having heart attack symptoms, according to new research published in Circulation: Cardiovascular Quality and Outcomes, a journal of the American Heart Association.

Pharmacyclics's Phase III RESONATE™ trial shows adherence to 420mg dose of IMBRUVICA improves outcomes in CLL patients

Pharmacyclics LLC today highlighted results from a sub-analysis of the Phase III RESONATE™ (PCYC-1112) trial, which found that previously-treated patients with chronic lymphocytic leukemia (CLL) who adhered to the recommended 420 mg dose of IMBRUVICA® (ibrutinib) experienced improved progression-free survival (PFS; the primary endpoint) as assessed by an Independent Review Committee (IRC), compared to patients who took lower doses or missed doses, regardless of high-risk genetic factors.

How Obamacare coverage is shaking out

Even with the health law's insurance options, consumers struggling with chronic diseases may still face such high out-of-pocket costs on some plans that they could have trouble staying out of debt, reports the Associated Press. Meanwhile, several major drugstore chains are offering to fill prescriptions for those who enrolled in new health plans but don't have ID numbers yet.

Paul J Mainella, MD - Emergency Medicine in Barrington, RI